HOME >> MEDICINE >> NEWS
AACR supports the nomination of Andrew von Eschenbach as the commissioner of the FDA

PHILADELPHIA The American Association for Cancer Research, the world's oldest and largest organization dedicated to cancer research, enthusiastically supports the nomination of Andrew von Eschenbach as new commissioner of the U.S. Food and Drug Administration.

"Dr. von Eschenbach brings enormous medical and administrative expertise and experience to this post," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "This background will be vitally important in his new challenging role of FDA commissioner."

In the cancer community, Dr. von Eschenbach, 64, is a well-recognized urologic surgeon who formerly directed the Genitourinary Cancer Center and the Prostate Cancer Research Program at The University of Texas M. D. Anderson Cancer Center. Dr. von Eschenbach spent a quarter of a century there, moving from faculty member to department chair to executive vice president and chief academic officer.

Subsequently, Dr. von Eschenbach was named Director of the National Cancer Institute, the 12th person to assume this responsibility in the NCI's 67-year old history. During his tenure, he worked to strengthen collaborations between the NCI and the FDA, and to bring laboratory breakthroughs to the clinic as quickly as possible, maximizing patient benefits and minimizing risks. As part of this collaboration, the NCI and FDA through a joint agency task force agreed to share knowledge and resources to facilitate the development of new cancer drugs and speed their delivery to patients.

"Dr. von Eschenbach also has a special appreciation for translational cancer research, the process that bridges basic research with clinical research, with the goal of bringing new discoveries to the cancer patient," said Peter Jones, Ph.D., D.Sc., AACR president and director of the University of Southern California/Norris Comprehensive Cancer Center and Distinguished Professor of Urology and Biochemistry & Molecular Biolog
'"/>

Contact: Warren R. Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
15-Mar-2006


Page: 1 2

Related medicine news :

1. Michigan-CDC study supports value of social restrictions during influenza pandemics
2. ACP supports improved access to information on relative strengths and weaknesses
3. Study supports activity of GEMZAR in the treatment of early-stage breast cancer
4. New research supports early testing for prostate cancer
5. ACP enthusiastically supports introduction of Bipartisan Health CARE Act
6. ACP supports new bill to promote adoption of health information technology
7. New data supports a non-invasive approach to routine prenatal genetic testing
8. Existing research supports metabolic syndrome link to cardiovascular disease
9. Medscape review supports effectiveness and safety of new non-drug blood pressure treatment
10. New study supports major change in diet treatment for diabetes
11. Wild vs. lab rodent comparison supports hygiene hypothesis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... , ... September 17, 2019 , ... ... availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:9/14/2019)... ... September 13, 2019 , ... ... studies on the detection and treatment of infectious diseases at its annual ... studies were noninvasive detection of residual HIV infected cell persistence and the ...
(Date:9/11/2019)... , ... September 11, 2019 , ... A September 2 ... had undergone weight loss surgery were significantly less likely to suffer heart attacks, strokes, ... not undergo bariatric surgery. Los Angeles-based weight loss surgery specialists Dr. Feiz and Associates ...
(Date:9/11/2019)... ... , ... Autopsies don’t lie. They report the causes of death as ... harms the heart. It increases risks of heart attack and death. Autopsies ... damage occurs. , An August 1, 2019 article in U.S. News ...
(Date:9/11/2019)... (PRWEB) , ... September 10, 2019 , ... ... to the team. Dr. Hesano is an understanding, caring and highly skilled Obstetrician/Gynecologist. ... high-risk obstetrical medicine. Dr. Hesano strives to ensure that each visit is comfortable, ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... Calif. (PRWEB) , ... September 17, 2019 , ... Summer is a time for barbecues, ... is good for our teeth and gums. Dr. Douglas Ng, family dentist in San ... weather is the time for ice cream, and popsicles and ice-filled cold drinks to go ...
(Date:9/14/2019)... ... 13, 2019 , ... Corey Stern , a partner at Levy Konigsberg, ... Archibald over at least 3 decades while employed by Rockefeller University Hospital (“RUH”). ... Court - Southern District of New York, No. 1:19-cv-01403), the first case filed against ...
(Date:9/14/2019)... ... September 14, 2019 , ... On ... with peritoneal mesothelioma, a jury in Middlesex County found Johnson & Johnson liable ... alleging their mesotheliomas were caused by asbestos-containing J&J talc products. , ...
Breaking Medicine Technology:
Cached News: